title: [Beta-blockers in portal hypertension: Unexpected limitations!].
authors.forename: Thierry
authors.initials: T
authors.lastname: Thevenot
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Cervoni
authors.forename: Vincent
authors.initials: V
authors.lastname: Di Martino
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use*; D002423:Cause of Death; D004932:Esophageal and Gastric Varices / Q000188:drug therapy / Q000401:mortality; D004945:Esophagoscopy; D006471:Gastrointestinal Hemorrhage / Q000401:mortality / Q000517:prevention & control; D006801:Humans; D006975:Hypertension, Portal / Q000188:drug therapy* / Q000401:mortality; D008026:Ligation; D008103:Liver Cirrhosis / Q000150:complications / Q000401:mortality; D008113:Liver Neoplasms / Q000150:complications / Q000401:mortality; D015999:Multivariate Analysis; D011433:Propranolol / Q000009:adverse effects* / Q000627:therapeutic use*; D012307:Risk Factors; D012422:Rupture, Spontaneous; D055502:Secondary Prevention; D015996:Survival Rate
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol